WhiteLab Genomics

Revolutionary AI platform to change the paradigm of gene therapy developments.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Paris, France
  • Currency EUR
  • Founded February 2019
  • Employees 4
  • Incorporation Type Other
  • Website whitelabgx.com

Company Summary

Gene therapies are a booming new generation of medicines tackling diseases directly at the DNA level. Unfortunately only few therapies are available in the market today due to a very high cost of development. WhiteLab Genomics is developing a unique AI platform to drastically change the way gene therapies are developed, thanks to the aggregation and validation of unique data sets, setting up standards and enabling safer/faster drug development.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free